Adjacent segment disease after minimally invasive transforaminal lumbar interbody fusion for degenerative lumbar diseases: incidence and risk factors

被引:13
|
作者
Yuan, Chao [1 ]
Zhou, Jing [2 ]
Wang, Liran [2 ]
Deng, Zhongliang [1 ]
机构
[1] Chongqing Med Univ, Affiliated Hosp 2, Dept Orthopaed, 76 Linjiang Rd, Chongqing 400010, Peoples R China
[2] Army Med Univ, Affiliated Xinqiao Hosp, Dept Orthopaed Surg, 183 Xingiao St, Chongqing 183, Peoples R China
关键词
Adjacent segment disease; Minimally invasive transforaminal lumbar interbody fusion; Degenerative lumbar diseases; Risk factors; INTERVERTEBRAL DISC DEGENERATION; SURGERY; INSTRUMENTATION; SMOKING; MUSCLE; TERM;
D O I
10.1186/s12891-022-05905-6
中图分类号
R826.8 [整形外科学]; R782.2 [口腔颌面部整形外科学]; R726.2 [小儿整形外科学]; R62 [整形外科学(修复外科学)];
学科分类号
摘要
Study design Retrospective study. Objectives To explore the incidence and risk factors for symptomatic adjacent segment disease (ASD) in patients enveloped in degenerative lumbar diseases after minimally invasive transforaminal lumbar interbody fusion (MIS-TLIF). Methods Data were retrospectively analyzed on 744 patients who underwent MIS-TLIF for degenerative lumbar diseases in our hospital from October 2012 to December 2018. The patients were divided into the ASD group and non-ASD (N-ASD) group on the basis of developing ASD at follow-up, and then the incidence of ASD was calculated. Clinical and radiological risk factors were assessed over time to determine their association with ASD by excluding less important factors. Results Data were missing for 26 patients, while a total of 718 patients were successfully monitored after MIS-TLIF. Of the 718 individuals participated in the study, 34 (4.7%) patients plagued by ASD required surgical intervention. The average onset time of ASD was 62.7 +/- 15.1 months. Univariate analysis results shows that age, bone mineral density (BMD), body mass index (BMI), preoperative adjacent intervertebral disc height and preoperative adjacent segment disc degeneration were significantly different between the ASD and N-ASD groups (p < 0.05). The logistic regression analysis results demonstrated that BMD (p = 0.039, OR = 0.986, 95% CI 0.899-1.115), BMI (p = 0.041, OR = 1.119, 95% CI 1.103-2.397), and preoperative adjacent intervertebral disc degeneration (p = 0.023, OR = 1.215, 95% CI 1.015-1.986) may be seen as risk factors for ASD after MIS-TLIF. Conclusions The incidence of ASD was about 4.7% in patients suffer from degenerative lumbar diseases after MIS-TLIF. BMD, BMI and preoperative adjacent intervertebral disc degeneration might be the risk factors for the occurrence of ASD after MIS-TLIF. Our research also suggested that patients with lower BMD, higher BMI and disc preoperative adjacent segment disc degeneration were more likely to develop ASD after MIS-TLIF.
引用
下载
收藏
页数:8
相关论文
共 50 条
  • [31] Radiographic and Clinical Outcomes of Oblique Lateral Interbody Fusion Versus Minimally Invasive Transforaminal Lumbar Interbody Fusion for Degenerative Lumbar Disease
    Li, Hui-Min
    Zhang, Ren-Jie
    Shen, Cai-Liang
    WORLD NEUROSURGERY, 2019, 122 : E627 - E638
  • [32] Minimally invasive transforaminal lumbar interbody fusion versus oblique lateral interbody fusion for lumbar degenerative disease: a meta-analysis
    Zhang, Qing-Yi
    Tan, Jie
    Huang, Kai
    Xie, Hui-Qi
    BMC MUSCULOSKELETAL DISORDERS, 2021, 22 (01)
  • [33] Minimally invasive transforaminal lumbar interbody fusion versus oblique lateral interbody fusion for lumbar degenerative disease: a meta-analysis
    Qing-Yi Zhang
    Jie Tan
    Kai Huang
    Hui-Qi Xie
    BMC Musculoskeletal Disorders, 22
  • [34] Factors associated with readmission after minimally invasive transforaminal lumbar interbody fusion
    Tumialan, Luis M.
    Weinstein, Nolan
    Farber, S. Harrison
    Desai, Shashvat M.
    Marciano, Frederick F.
    JOURNAL OF NEUROSURGERY-SPINE, 2023, 38 (06) : 681 - 687
  • [35] A comparison of minimally invasive transforaminal lumbar interbody fusion and decompression alone for degenerative lumbar spondylolisthesis
    Chan, Andrew K.
    Bisson, Erica F.
    Bydon, Mohamad
    Glassman, Steven D.
    Foley, Kevin T.
    Potts, Eric A.
    Shaffrey, Christopher, I
    Shaffrey, Mark E.
    Coric, Domagoj
    Knightly, John J.
    Park, Paul
    Wang, Michael Y.
    Fu, Kai-Ming
    Slotkin, Jonathan R.
    Asher, Anthony L.
    Virk, Michael S.
    Kerezoudis, Panagiotis
    Alvi, Mohammed Ali
    Guan, Jian
    Haid, Regis W.
    Mummaneni, Praveen, V
    NEUROSURGICAL FOCUS, 2019, 46 (05)
  • [36] Comparison of midline lumbar interbody fusion and minimally invasive transforaminal lumbar interbody fusion for treatment of lumbar degeneration disease
    Xuelei Zhang
    Yu Zhang
    Zuchao Gu
    Guo Li
    Scientific Reports, 14 (1)
  • [37] Instrumentation-related complications of lumbar degenerative disc diseases treated by minimally invasive transforaminal lumbar interbody fusion
    Xinyu Yang
    Xinyu Liu
    Brain Science Advances, 2019, 5 (03) : 213 - 219
  • [38] Percutaneous endoscopic versus minimally invasive transforaminal lumbar interbody fusion for lumbar degenerative diseases: a meta-analysis
    Song, Yi-Fan
    Wang, Hui
    Zhang, Jian-Wei
    Li, Yi-Ming
    Xue, You-Di
    Fu, Yu-Fei
    Li, Jie
    VIDEOSURGERY AND OTHER MINIINVASIVE TECHNIQUES, 2022, 17 (04) : 591 - 600
  • [39] Comparing the efficacy of unilateral biportal endoscopic transforaminal lumbar interbody fusion and minimally invasive transforaminal lumbar interbody fusion in lumbar degenerative diseases: a systematic review and meta-analysis
    Luan, Haopeng
    Peng, Cong
    Liu, Kai
    Song, Xinghua
    JOURNAL OF ORTHOPAEDIC SURGERY AND RESEARCH, 2023, 18 (01)
  • [40] Surgery for degenerative lumbar disease: transforaminal lumbar interbody fusion
    Grob, Dieter
    EUROPEAN SPINE JOURNAL, 2009, 18 (12) : 1991 - 1992